Multiple sclerosis following etanercept treatment for ankylosing spondylitis

Scandinavian Journal of Rheumatology

Volumn 37, Issue 5, 2008, Pages 397-399

  Pfueller, C F ^a   Seipelt, E ^b   Zipp, F ^a   Paul, F ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Rheumaklinik Berlin Buch   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ANKYLOSING SPONDYLITIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DEMYELINATING DISEASE; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PARESTHESIA; PRIORITY JOURNAL; RELAPSE;

ADULT; ANTIRHEUMATIC AGENTS; BRAIN; FEMALE; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; RECEPTORS, TUMOR NECROSIS FACTOR; RISK FACTORS; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52949092224     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740802136164     Document Type: Letter

References (10)

1. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-7.
2. Calin A. Is there an association between ankylosing spondylitis and multiple sclerosis? Ann Rheum Dis 1989;48:971-2.
3. Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis: experience of the optic neuritis treatment trial. 1997. Neurology 2001;57(12 Suppl 5):S36-45.
4. Sicotte NL, Voskuhl RR. Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 2001;57:1885-8.
5. Gomez-Gallego M, Meca-Lallana J, Fernandez-Barreiro A. Multiple sclerosis onset during etanercept treatment. Eur Neurol 2008;59:91-3.
6. Enayati PJ, Papadakis KA. Association of anti-tumor necrosis factor therapy with the development of multiple sclerosis. J Clin Gastroenterol 2005;39:303-6.
7. Bellesi M, Logullo F, Di Bella P, Provinciali L. CNS demyelination during anti-tumor necrosis factor alpha therapy. J Neurol 2006;253:668-9.
8. Bensouda-Grimaldi L, Mulleman D, Valat JP, Autret-Leca E. Adalimumab-associated multiple sclerosis. J Rheumatol 2007;34:239-40.
9. Magnano MD, Robinson WH, Genovese MC. Demyelination and inhibition of tumor necrosis factor (TNF). Clin Exp Rheumatol 2004;22(5 Suppl 35):S134-40.
10. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 1999;53:457-65.